Q64729 (TGFR1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 128.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: TGF-beta receptor type-1 Short name=TGFR-1 EC=2.7.11.30 Alternative name(s): ESK2 Transforming growth factor-beta receptor type I Short name=TGF-beta receptor type I Short name=TbetaR-I | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 503 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation By similarity. |
| Catalytic activity | ATP + [receptor-protein] = ADP + [receptor-protein] phosphate. |
| Cofactor | Magnesium or manganese By similarity. |
| Enzyme regulation | Kept in an inactive conformation by FKBP1A preventing receptor activation in absence of ligand. CD109 is another inhibitor of the receptor By similarity. |
| Subunit structure | Homodimer; in the endoplasmic reticulum but also at the cell membrane. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands assemble a functional receptor composed of two TGFBR1 and TGFBR2 heterodimers to form a ligand-receptor heterohexamer. The respective affinity of TGBRB1 and TGFBR2 for the ligands may modulate the kinetics of assembly of the receptor and may explain the different biological activities of TGFB1, TGFB2 and TGFB3. Interacts with CD109; inhibits TGF-beta receptor activation in keratinocytes. Interacts with RBPMS. Interacts (unphosphorylated) with FKBP1A; prevents TGFBR1 phosphorylation by TGFBR2 and stabilizes it in the inactive conformation. Interacts with SMAD2, SMAD3 and ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-beta receptor. Interacts with TRAF6 and MAP3K7; induces MAP3K7 activation by TRAF6. Interacts with PARD6A; involved in TGF-beta induced epithelial to mesenchymal transition. Interacts with SMAD7, NEDD4L, SMURF1 and SMURF2; SMAD7 recruits NEDD4L, SMURF1 and SMURF2 to the TGF-beta receptor By similarity. Interacts with USP15 and VPS39 By similarity. |
| Subcellular location | Cell membrane; Single-pass type I membrane protein By similarity. Cell junction › tight junction By similarity. |
| Post-translational modification | Phosphorylated at basal levels in the absence of ligand. Activated upon phosphorylation by TGFBR2, mainly in the GS domain. Phosphorylation in the GS domain abbrogates FKBP1A-binding By similarity. N-Glycosylated By similarity. Ubiquitinated; undergoes ubiquitination catalyzed by several E3 ubiquitin ligases including SMURF1, SMURF2 and NEDD4L2. Results in the proteasomal and/or lysosomal degradation of the receptor thereby negatively regulating its activity. Deubiquitinated by USP15, leading to stabilization of the protein and enhanced TGF-beta signal By similarity. |
| Sequence similarities | Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily. Contains 1 GS domain. Contains 1 protein kinase domain. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q64729-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q64729-2) The sequence of this isoform differs from the canonical sequence as follows: 111-114: Missing. | ||||||
| Note: May be due to a competing donnor splice site. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | By similarity | ||||||||
| Chain | 30 – 503 | 474 | TGF-beta receptor type-1 | PRO_0000024424 | |||||||
Regions | |||||||||||
| Topological domain | 30 – 126 | 97 | Extracellular Potential | ||||||||
| Transmembrane | 127 – 147 | 21 | Helical; Potential | ||||||||
| Topological domain | 148 – 503 | 356 | Cytoplasmic Potential | ||||||||
| Domain | 175 – 204 | 30 | GS | ||||||||
| Domain | 205 – 495 | 291 | Protein kinase | ||||||||
| Nucleotide binding | 211 – 219 | 9 | ATP By similarity | ||||||||
| Motif | 193 – 194 | 2 | FKBP1A-binding | ||||||||
Sites | |||||||||||
| Active site | 333 | 1 | Proton acceptor By similarity | ||||||||
| Binding site | 232 | 1 | ATP By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 165 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 185 | 1 | Phosphothreonine; by TGFBR2 By similarity | ||||||||
| Modified residue | 186 | 1 | Phosphothreonine; by TGFBR2 By similarity | ||||||||
| Modified residue | 187 | 1 | Phosphoserine; by TGFBR2 By similarity | ||||||||
| Modified residue | 189 | 1 | Phosphoserine; by TGFBR2 By similarity | ||||||||
| Modified residue | 191 | 1 | Phosphoserine; by TGFBR2 By similarity | ||||||||
| Glycosylation | 41 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 32 ↔ 50 | By similarity | |||||||||
| Disulfide bond | 34 ↔ 37 | By similarity | |||||||||
| Disulfide bond | 44 ↔ 67 | By similarity | |||||||||
| Disulfide bond | 82 ↔ 96 | By similarity | |||||||||
| Disulfide bond | 97 ↔ 102 | By similarity | |||||||||
| Cross-link | 391 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 111 – 114 | 4 | Missing in isoform 2. | VSP_021593 | |||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning of a mouse counterpart for human TGF-beta type I receptor." Tomoda T., Kudoh T., Noma T., Nakazawa A., Muramatsu M.-A., Arai K. Biochem. Biophys. Res. Commun. 198:1054-1062(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Brain and Testis. |
| [2] | "A mouse TGF-beta type I receptor that requires type II receptor for ligand binding." Suzuki A., Shioda N., Maeda T., Tada M., Ueno N. Biochem. Biophys. Res. Commun. 198:1063-1069(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: Brain. |
| [3] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Strain: C57BL/6. Tissue: Brain. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | D28526 mRNA. Translation: BAA05878.1. D25540 mRNA. Translation: BAA05023.1. AL772232, AL772150 Genomic DNA. Translation: CAM13897.1. AL772150, AL772232 Genomic DNA. Translation: CAM24923.1. BC063260 mRNA. Translation: AAH63260.1. |
| IPI | IPI00137994. IPI00649475. |
| PIR | JC2061. JC2062. |
| RefSeq | NP_033396.1. NM_009370.2. |
| UniGene | Mm.197552. |
3D structure databases | |
| ProteinModelPortal | Q64729. |
| SMR | Q64729. Positions 27-110, 175-500. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-42262N. |
| IntAct | Q64729. 4 interactions. |
| MINT | MINT-1341331. |
PTM databases | |
| PhosphoSite | Q64729. |
Proteomic databases | |
| PRIDE | Q64729. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000007757; ENSMUSP00000007757; ENSMUSG00000007613. ENSMUST00000044234; ENSMUSP00000048501; ENSMUSG00000007613. |
| GeneID | 21812. |
| KEGG | mmu:21812. |
| UCSC | uc008suo.1. mouse. |
Organism-specific databases | |
| CTD | 7046. |
| MGI | MGI:98728. Tgfbr1. |
Phylogenomic databases | |
| eggNOG | COG0515. |
| GeneTree | ENSGT00560000076615. |
| HOGENOM | HOG000230587. |
| HOVERGEN | HBG054502. |
| InParanoid | Q64729. |
| KO | K04674. |
| OMA | CISLMLI. |
| OrthoDB | EOG4JQ3XG. |
Enzyme and pathway databases | |
| BRENDA | 2.7.10.2. 3474. |
Gene expression databases | |
| ArrayExpress | Q64729. |
| Bgee | Q64729. |
| CleanEx | MM_TGFBR1. |
| Genevestigator | Q64729. |
| GermOnline | ENSMUSG00000007613. Mus musculus. |
Family and domain databases | |
| InterPro | IPR000472. Activin_rcpt. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR008271. Ser/Thr_kinase_AS. IPR003605. TGF_beta_rcpt_GS. [Graphical view] |
| Pfam | PF01064. Activin_recp. 1 hit. PF00069. Pkinase. 1 hit. PF08515. TGF_beta_GS. 1 hit. [Graphical view] |
| SMART | SM00467. GS. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS51256. GS. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TGFBR1. mouse. |
| NextBio | 301202. |
| SOURCE | Search... |
Entry information
| Entry name | TGFR1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q64729 Secondary accession number(s): A2AJN0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
